Skip to content

the efficacy of HYTRIN in the treatment of distal ureteral stone

the efficacy of HYTRIN in the treatment of distal ureteral stone

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCN-15006052
Enrollment
Unknown
Registered
2015-03-07
Start date
2015-03-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

distal ureteral stone

Interventions

The test group and the control group:HYTRIN vs Placebo

Sponsors

Jiangning Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ranging in age from 18 to 46; 2. Single ureteral calculi; 3. Stone diameter in 4-6mm.

Exclusion criteria

Exclusion criteria: Interruption of treatment

Design outcomes

Primary

MeasureTime frame
removing urinary calculus;

Countries

China

Contacts

Public ContactLu Jianlin
ljlxx01@163.com+86 13770631917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026